Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 54.85
(-1.7%)
CNY 54.85
(-1.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6 Billion | 6.35 Billion | 4.94 Billion | 2.63 Billion | 1.88 Billion | 1.26 Billion |
| Cost of Revenue | 1.72 Billion | 1.46 Billion | 1.08 Billion | 489.47 Million | 383.56 Million | 253.58 Million |
| Gross Profit | 4.28 Billion | 4.89 Billion | 3.86 Billion | 2.14 Billion | 1.5 Billion | 1 Billion |
| Operating Expenses | 3.7 Billion | 3.78 Billion | 2.94 Billion | 1.38 Billion | 800.65 Million | 518 Million |
| Selling, General and Administrative Expenses | 3.33 Billion | 3.17 Billion | 2.53 Billion | 1.13 Billion | 563.99 Million | 337.97 Million |
| Research and Development Expenses | 446.34 Million | 388.18 Million | 284.33 Million | 141.15 Million | 93.88 Million | 52.86 Million |
| Other Expenses | -76.19 Million | 220.03 Million | 130.52 Million | 104.17 Million | 142.77 Million | -9.46 Million |
| Cost and Expenses | 5.36 Billion | 5.24 Billion | 4.03 Billion | 1.87 Billion | 1.18 Billion | 771.58 Million |
| Operating Income | 708.38 Million | 1.13 Billion | 905.55 Million | 757.04 Million | 699.57 Million | 524.44 Million |
| Interest Expense | 11.56 Million | 14.52 Million | 11.08 Million | 517.06 Thousand | 1.63 Million | 148.48 Thousand |
| Income Tax Expense | 118.98 Million | 174.73 Million | 114.64 Million | 113.88 Million | 116.47 Million | 91.12 Million |
| Earnings before Tax | 701.72 Million | 1.13 Billion | 890.19 Million | 758.89 Million | 701.09 Million | 514.98 Million |
| Net Income | 592.55 Million | 970.91 Million | 782.33 Million | 645.83 Million | 585.6 Million | 423.85 Million |
| Earnings Per Share Basic | 1.23 | 2.02 | 1.63 | 1.35 | 1.22 | 0.98 |
| Earnings Per Share Diluted | 1.23 | 2.02 | 1.62 | 1.35 | 1.22 | 0.97 |
| Weighted Average Shares Outstanding | 481.75 Million | 480.65 Million | 480 Million | 480 Million | 480 Million | 430.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 481.75 Million | 481.08 Million | 482.92 Million | 480 Million | 480 Million | 437.02 Million |
| Gross Margin | 0.71 | 0.77 | 0.78 | 0.81 | 0.80 | 0.80 |
| EBIT Margin | 0.17 | 0.22 | 0.22 | 0.33 | 0.41 | 0.45 |
| Profit Margin | 0.10 | 0.15 | 0.16 | 0.25 | 0.31 | 0.34 |
| EBITDA | 1 Billion | 1.38 Billion | 1.06 Billion | 840.39 Million | 766.33 Million | 564.03 Million |
| Earnings Before Tax Margin | 0.12 | 0.18 | 0.18 | 0.29 | 0.37 | 0.42 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.06 Billion | 1.43 Billion | 1.34 Billion | 1.83 Billion | 6 Billion | 1.14 Billion |
| Cost of Revenue | 293.9 Million | 419.03 Million | 330.18 Million | 514.49 Million | 1.72 Billion | 330.79 Million |
| Gross Profit | 770.09 Million | 1.01 Billion | 1.01 Billion | 1.31 Billion | 4.28 Billion | 815.02 Million |
| Operating Expenses | 743.03 Million | 914.07 Million | 732.27 Million | 1.25 Billion | 3.71 Billion | 719.55 Million |
| Selling, General and Administrative Expenses | 1.13 Billion | 805.95 Million | 629.39 Million | 1.04 Billion | - | 783.82 Million |
| Research and Development Expenses | 112.57 Million | 93.44 Million | 95.74 Million | 157.98 Million | - | 90.4 Million |
| Other Expenses | -500.62 Million | -14.67 Million | -7.13 Million | -50.59 Million | -33.78 Million | 242.63 Thousand |
| Cost and Expenses | 1.03 Billion | 1.33 Billion | 1.06 Billion | 1.77 Billion | 5.44 Billion | 1.05 Billion |
| Operating Income | 19.84 Million | 97.61 Million | 283.03 Million | 61.89 Million | 568.04 Million | 93.55 Million |
| Interest Expense | - | 2.2 Million | 1.29 Million | 1.1 Million | 6.23 Million | -835.95 Thousand |
| Income Tax Expense | 611.54 Thousand | 19.69 Million | 57.21 Million | 15.63 Million | 118.98 Million | 8.27 Million |
| Earnings before Tax | 19.15 Million | 118.83 Million | 302.61 Million | 91.49 Million | 703.37 Million | 93.79 Million |
| Net Income | 20.25 Million | 98.39 Million | 243.36 Million | 78.15 Million | 592.55 Million | 89.79 Million |
| Earnings Per Share Basic | 0.04 | 0.21 | 0.51 | 0.16 | - | 0.19 |
| Earnings Per Share Diluted | 0.04 | 0.21 | 0.51 | 0.16 | - | 0.19 |
| Weighted Average Shares Outstanding | 478.36 Million | 478.36 Million | 478.63 Million | 480.25 Million | 480.25 Million | 481.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 478.36 Million | 478.36 Million | 478.63 Million | 480.25 Million | 480.25 Million | 481.58 Million |
| Gross Margin | 0.72 | 0.71 | 0.75 | 0.72 | 0.71 | 0.71 |
| EBIT Margin | 0.02 | 0.13 | 0.25 | 0.07 | - | 0.09 |
| Profit Margin | 0.02 | 0.07 | 0.18 | 0.04 | 0.10 | 0.08 |
| EBITDA | 17.3 Million | 179.36 Million | 331.97 Million | 136.91 Million | - | 97.78 Million |
| Earnings Before Tax Margin | 0.02 | 0.07 | 0.21 | 0.03 | 0.09 | 0.08 |
SICALLOG
TAST
VCON
PANXF
AFT
IOS